课题基金 / 基金详情

A STUDY FROM THE CELLULAR ASPECT ON THE PATHOPHYSIOLOGY AND TREATMENT OF MULTIPLE ORGAN FAILURE

A STUDY FROM THE CELLULAR ASPECT ON THE PATHOPHYSIOLOGY AND TREATMENT OF MULTIPLE ORGAN FAILURE
从细胞角度研究多器官衰竭的病理生理学和治疗
批准号:
02454351
负责人:
HIRASAWA Hiroyuki
金额:
$4.29万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1992

项目摘要

项目成果

HIRASAWA Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
多器官功能衰竭(multiple organ failure,MOF)是重要器官细胞损伤的总和。因此,应考虑通过改善重要器官的细胞功能障碍来治疗MOF。对于这种方法,能够表达细胞损伤严重程度的参数是必不可少的。我们提出的细胞损伤评分(cellular injury score,CIS)是根据动脉血酮体比率(AKBR)、血清渗透压差(osmolality gap)和血乳酸(blood lactate)三种不同的细胞代谢序列计算的,是一个很好的评价多器官功能衰竭患者病情严重程度的指标。脓毒症、创伤和休克等多种损伤后细胞功能的损害可通过两种机制引起:组织氧代谢紊乱和体液介质。因此,治疗和/或预防危重病细胞损伤应通过改善组织氧代谢和对抗体液介质来实现。我们已经发现,连续性血液滤过(CHF)/连续性血液透析滤过(CHDF)可有效清除各种体液介质,并且这些连续性血液净化也可有效改善儿茶酚胺给药后的组织氧代谢。这些结果表明,改善细胞功能障碍是MOF的有效治疗/预防。
英文摘要
We have claimed that multiple organ failure (MOF) is the summation of the cellular injury in vital organs. Therefore therapeutic approaches to the MOF should be considered through the improvement of cellular dysfunction in the vital organs. For such approach the parameters which can express the severity of cellular injury is essential. The cellular injury score (CIS), which is derived from three different cellular metabolic sequences, arterial ketone body ratio (AKBR), serum osmolality gap and blood lactate and is proposed by us is found to be a good index to evaluate the severity of the patients with MOF. The impairment of cellular function following various insults such as sepsis, trauma, and shock can be caused through two mechanism: derangement in tissue oxygen metabolism and humoral mediators. Therefore for the treatment and/or prevention of cellular injury in the critically ill should be achieved through the improvement of tissue oxygen metabolism and the counter-measures for the humoral mediators. We have found that continuous hemofiltration (CHF)/continuous hemodiafiltration(CHDF) effectively remove the various humoral mediators and that those continuous blood purifications are also effective in the improvement of tissue oxygen metabolism following the administration of catecholamines. These results suggest that improvement of cellular dysfunction is an effective treatment/prophylaxis for MOF.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
志賀 英敏: "MOF患者の全身状態評価法としてのAPACHE II、CISおよびAPACHE Hの比較" 外科と代謝・栄養. 27. 21-28 (1992)
Hidetoshi Shiga:“APACHE II、CIS 和 APACHE H 作为评估 MOF 患者一般状况的方法的比较”《外科、代谢和营养》27. 21-28 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
平澤 博之: "MOF治療 -最近の動向-" 綜合臨牀. 40. 2629-2636 (1991)
Hiroyuki Hirasawa:“MOF 治疗 - 最新趋势 -” Sogo Rinpo。40. 2629-2636 (1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
平澤 博之: "細胞レベルからみた細胞障害とその対策 分担執筆 「臓器障害と細胞代謝」" メジカルビュ-社, 10 (1990)
Hiroyuki Hirasawa:“细胞损伤及其从细胞水平的对策。撰稿人:“器官损伤和细胞代谢”,Medical View-sha,10(1990)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
志賀 英敏: "MOF患者の全身状態評価法としてのAPACHEII、CISおよびAPACHE Hの比較" 外科と代謝・栄養. 27. 21-28 (1992)
Hidetoshi Shiga:“APACHE II、CIS 和 APACHE H 作为评估 MOF 患者一般状况的方法的比较”《外科、代谢和营养》27. 21-28 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 22 条
    TAILOR-MADE MEDICINE AGAINST PATHOPHYSIOLOGICAL RESPONSE TO STRESS BASED ON THE GENOME ANALYSIS
    • 批准号:
      14370348
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $5.63万
    • 财政年份:
      2002
    • 负责人:
      HIRASAWA Hiroyuki
    • 依托单位:
    Cytokine modulation with continuous hemodiafiltration for treatment and prevention of multiple organ failure
    • 批准号:
      11470238
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.96万
    • 财政年份:
      1999
    • 负责人:
      HIRASAWA Hiroyuki
    • 依托单位:
    ENHANCEMENT OF RETICULOENDOTHELIAL FUNCTION IN THE TREATMENT OF ACUTE HEPATIC FAILURE
    • 批准号:
      61570734
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1986
    • 负责人:
      HIRASAWA Hiroyuki
    • 依托单位:
    海外基金